Mindy Chen

577 total citations
18 papers, 384 citations indexed

About

Mindy Chen is a scholar working on Ophthalmology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mindy Chen has authored 18 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Ophthalmology, 6 papers in Rheumatology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mindy Chen's work include Ocular Diseases and Behçet’s Syndrome (5 papers), Otitis Media and Relapsing Polychondritis (4 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Mindy Chen is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (5 papers), Otitis Media and Relapsing Polychondritis (4 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Mindy Chen collaborates with scholars based in United States, Japan and South Korea. Mindy Chen's co-authors include Maria Paris, Sue Cheng, Shannon McCue, Mitsuhiro Takeno, Gülen Hatemi, Alfred Mahr, Yusuf Yazıcı, Melike Melikoğlu, Do Young ‍Kim and Christian Swinney and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mindy Chen

17 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mindy Chen United States 9 130 129 113 95 64 18 384
Sung‐Hwan Park South Korea 9 55 0.4× 138 1.1× 10 0.1× 99 1.0× 9 0.1× 11 384
Yeong-Wook Song South Korea 8 67 0.5× 207 1.6× 10 0.1× 89 0.9× 47 0.7× 13 382
Alyx Rosen United States 12 11 0.1× 34 0.3× 174 1.5× 43 0.5× 70 1.1× 19 507
Xiaoying Sun China 12 6 0.0× 240 1.9× 53 0.5× 71 0.7× 12 0.2× 25 393
Hee Jung Ryu South Korea 11 73 0.6× 191 1.5× 8 0.1× 92 1.0× 29 0.5× 22 320
Hiroyuki Irie Japan 9 3 0.0× 144 1.1× 90 0.8× 37 0.4× 52 0.8× 22 429
Chandrasena Pamulapati United States 6 11 0.1× 294 2.3× 218 1.9× 570 6.0× 5 0.1× 8 717
Corinne Duguet France 6 9 0.1× 154 1.2× 105 0.9× 24 0.3× 13 0.2× 7 530
Douglas W. Lienesch United States 6 4 0.0× 150 1.2× 25 0.2× 63 0.7× 26 0.4× 9 308
Makiko Yashiro Furuya Japan 9 7 0.1× 103 0.8× 12 0.1× 133 1.4× 37 0.6× 19 289

Countries citing papers authored by Mindy Chen

Since Specialization
Citations

This map shows the geographic impact of Mindy Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mindy Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mindy Chen more than expected).

Fields of papers citing papers by Mindy Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mindy Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mindy Chen. The network helps show where Mindy Chen may publish in the future.

Co-authorship network of co-authors of Mindy Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Mindy Chen. A scholar is included among the top collaborators of Mindy Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mindy Chen. Mindy Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sato, Takami, et al.. (2024). Real world tebentafusp-tebn experience at a tertiary care referral center.. Journal of Clinical Oncology. 42(16_suppl). e21526–e21526. 1 indexed citations
2.
Langley, Richard G., Nehal N. Mehta, Jeffrey Crowley, et al.. (2023). 43250 Efficacy of Apremilast in Patients With Moderate-to-Severe Plaque Psoriasis Across Weight and BMI Subgroups: Analysis From ESTEEM 1 and ESTEEM 2. Journal of the American Academy of Dermatology. 89(3). AB158–AB158. 3 indexed citations
3.
Merola, Joseph F., Lawrence Charles Parish, Lyn Guenther, et al.. (2023). Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology. 90(3). 485–493. 13 indexed citations
4.
5.
Kolb, Jennifer M., Mindy Chen, Anna Tavakkoli, et al.. (2022). Patient Knowledge, Risk Perception, and Barriers to Barrett's Esophagus Screening. The American Journal of Gastroenterology. 118(4). 615–626. 7 indexed citations
6.
Hatemi, Gülen, Alfred Mahr, Mitsuhiro Takeno, et al.. (2022). Impact of apremilast on quality of life in Behçet’s syndrome: analysis of the phase 3 RELIEF study. RMD Open. 8(2). e002235–e002235. 8 indexed citations
7.
Gold, Linda Stein, Kim Papp, David M. Pariser, et al.. (2021). Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology. 86(1). 77–85. 38 indexed citations
8.
Hatemi, Gülen, Alfred Mahr, Mitsuhiro Takeno, et al.. (2021). Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial. Clinical and Experimental Rheumatology. 39(5). 80–87. 17 indexed citations
9.
Hatemi, Gülen, Alfred Mahr, Mitsuhiro Takeno, et al.. (2021). Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial.. Clinical and Experimental Rheumatology. 39 Suppl 132(5). 80–87. 5 indexed citations
10.
11.
Hatemi, Gülen, Alfred Mahr, Mitsuhiro Takeno, et al.. (2019). OP0146 EFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHÇET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY. Annals of the Rheumatic Diseases. 78. 148–149. 2 indexed citations
12.
Hatemi, Gülen, Alfred Mahr, Yoshiaki Ishigatsubo, et al.. (2019). Trial of Apremilast for Oral Ulcers in Behçet’s Syndrome. New England Journal of Medicine. 381(20). 1918–1928. 122 indexed citations
13.
Chen, Ming, et al.. (2019). A Pilot Study of the Short Term Effectiveness and Safety of Amniotic Fluid in Severe Dry Eye Disease.. PubMed. 8(2). 81–84. 5 indexed citations
14.
Simpson, Eric L., Shinichi Imafuku, Yves Poulin, et al.. (2018). A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis. Journal of Investigative Dermatology. 139(5). 1063–1072. 90 indexed citations
15.
Swinney, Christian, et al.. (2015). Comparing the intraoperative complication rate of femtosecond laser-assisted cataract surgery to traditional phacoemulsification.. SHILAP Revista de lepidopterología. 8(1). 201–3. 34 indexed citations
16.
Genovese, Mark C., Kateřina Jarošová, Dorota Cieślak, et al.. (2015). Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study. Arthritis & Rheumatology. 67(7). 1703–1710. 21 indexed citations
17.
Chen, Mindy, et al.. (2010). Comparison of CDE data in phacoemulsification between an open hospital-based ambulatory surgical center and a free-standing ambulatory surgical center. SHILAP Revista de lepidopterología. 4 indexed citations
18.
Chen, Mindy, et al.. (2009). A retrospective randomized study to compare the energy delivered using CDE with different techniques and OZil(®) settings by different surgeons in phacoemulsification. SHILAP Revista de lepidopterología. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung‐Hwan Park Breakdown of academic impact, for papers by Yeong-Wook Song Breakdown of academic impact, for papers by Alyx Rosen Breakdown of academic impact, for papers by Xiaoying Sun Breakdown of academic impact, for papers by Hee Jung Ryu Breakdown of academic impact, for papers by Hiroyuki Irie Breakdown of academic impact, for papers by Chandrasena Pamulapati Breakdown of academic impact, for papers by Corinne Duguet Breakdown of academic impact, for papers by Douglas W. Lienesch Breakdown of academic impact, for papers by Makiko Yashiro Furuya
Rankless by CCL
2026